Physician profile
Sara Stringfellow
NPI 1215564448
$1,420.24
in general payments reported to CMS, 2019-2025
15 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.07 · 2023: $53.44 · 2024: $111 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $800 · Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $800.00 |
| Food and Beverage | $556.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $800.00 | 2025 | Ardeograft, Surgraft, Vitograft |
| Mayne Pharma Commercial LLC | $120.03 | 2025 | |
| Biogen, INC. | $88.79 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $71.17 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $53.31 | 2024-2025 | Paragard T 380a |
| Exeltis, USA INC. | $45.94 | 2024-2025 | Slynd |
| Abbvie INC. | $42.65 | 2022 | |
| Sumitomo Pharma America, INC. | $40.31 | 2024-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $37.50 | 2024-2025 | Solosec, Phexx, Phexxi |
| Hologic Sales and Service, LLC | $23.14 | 2025 | Aptima |
| Millicent US INC | $22.54 | 2025 | Femlyv |
| Kci USA, INC. | $21.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.77 | 2023 | Exparel |
| Shield Therapeutics INC | $18.38 | 2023 | Accrufer |
| Dexcom, INC. | $16.29 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Stringfellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.